Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus

Area of Science:

• Immunology
• Rheumatology

Background:

• Complement activation and inefficient clearance of immune complexes contribute to systemic lupus erythematosus (SLE) pathogenesis.
• Elevated erythrocyte C4d and reduced complement receptor 1 (CD35) are observed in SLE, suggesting potential diagnostic value.

Purpose of the Study:

• To determine if erythrocyte C4d and CD35 are specific biomarkers for SLE.
• To investigate the association between these markers and SLE disease activity.

Main Methods:

• Indirect immunofluorescence and flow cytometry were used to measure erythrocyte C4d and CD35 expression.
• Measurements were performed on the same day as blood collection in SLE patients, other rheumatic disease patients, and healthy controls.

Main Results:

• No correlation was found between erythrocyte C4d/CD35 levels and SLE disease activity, physician's global assessment, or lupus nephritis.
• The assays lacked specificity for SLE, with elevated levels also detected in antiphospholipid syndrome.

Conclusions:

• The overlap of erythrocyte C4d and CD35 expression between SLE and other rheumatic diseases limits their diagnostic utility.
• Longitudinal studies are recommended, especially to explore elevated levels in primary antiphospholipid syndrome.